147
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Genetic Polymorphism of NQO1 Gene is Associated with Susceptibility of Ischemic Stroke in Chinese Han Nationality

, , , , , & show all
Pages 2211-2217 | Received 23 Jun 2022, Accepted 14 Sep 2022, Published online: 28 Sep 2022

References

  • Li Z, Jiang H, Ding Y, et al. Platelet endothelial aggregation receptor 1 polymorphism is associated with functional outcome in small-artery occlusion stroke patients treated with aspirin. Front Cardiovasc Med. 2021;8:664012. doi:10.3389/fcvm.2021.664012
  • Chen J, Yang C, Xu X, Yang Y, Xu B. The effect of focal cerebral ischemia-reperfusion injury on TLR4 and NF-kappaB signaling pathway. Exp Ther Med. 2018;15(1):897–903. doi:10.3892/etm.2017.5463
  • Zhuo Y, Chen W, Li W, et al. Ischemic-hypoxic preconditioning enhances the mitochondrial function recovery of transplanted olfactory mucosa mesenchymal stem cells via miR-181a signaling in ischemic stroke. Aging. 2021;13(8):11234–11256. doi:10.18632/aging.202807
  • Huang LY, Sun FR, Yin JJ, et al. Associations of the neutrophil to lymphocyte ratio with intracranial artery stenosis and ischemic stroke. BMC Neurol. 2021;21(1):56. doi:10.1186/s12883-021-02073-3
  • Zhu Q, Luo D, Zhou X, et al. A Model for risk prediction of cerebrovascular disease prevalence-based on community residents aged 40 and above in a city in China. Int J Environ Res Public Health. 2021;18(12). doi:10.3390/ijerph18126584
  • Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. doi:10.1038/s41419-020-2298-2
  • Peng Q, Lu Y, Lao X, et al. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol. 2014;9:100. doi:10.1186/1746-1596-9-100
  • Chiu MM, Ko YJ, Tsou AP, Chau GY, Chau YP. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma. Histol Histopathol. 2009;24(10):1223–1232. doi:10.14670/HH-24.1223
  • Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol. 1995;49(2):127–140. doi:10.1016/S0006-2952(94)00333-5
  • Boroumand M, Pourgholi L, Goodarzynejad H, et al. NQO1 C609T polymorphism is associated with coronary artery disease in a gender-dependent manner. Cardiovasc Toxicol. 2017;17(1):35–41. doi:10.1007/s12012-015-9353-8
  • Han SJ, Kang ES, Kim HJ, et al. The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes. Mol Genet Metab. 2009;97(1):85–90. doi:10.1016/j.ymgme.2009.01.012
  • Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer. 1997;75(1):69–75. doi:10.1038/bjc.1997.11
  • Traver RD, Horikoshi T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 1992;52(4):797–802.
  • Li GD, Han YS. 针刺治疗缺血性脑卒中的神经血管单元机制研究进展. [Research advances in neurovascular unit mechanism in acupuncture treatment of ischemic stroke]. Zhen Ci Yan Jiu. 2019;44(12):863–866. Chinese. doi:10.13702/j.1000-0607.190275
  • Li R, Li Y, Li B, et al. Effectiveness comparisons of different Chinese herbal injection therapies for acute cerebral infarction: a protocol for systematic review and network meta-analysis. Medicine. 2020;99(32):e21584. doi:10.1097/MD.0000000000021584
  • McNulty H, Strain JJ, Hughes CF, Pentieva K, Ward M. Evidence of a role for one-carbon metabolism in blood pressure: can B vitamin intervention address the genetic risk of hypertension owing to a common folate polymorphism? Curr Dev Nutr. 2020;4(1):nzz102. doi:10.1093/cdn/nzz102
  • Chauhan G, Debette S. Genetic risk factors for ischemic and hemorrhagic stroke. Curr Cardiol Rep. 2016;18(12):124. doi:10.1007/s11886-016-0804-z
  • Das L, Vinayak M. Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS One. 2015;10(4):e0124000. doi:10.1371/journal.pone.0124000
  • Parihar SS, Chauhan UK. The NQO1 allelic frequency in Hindu population of central India varies from that of other Asian populations. Indian J Hum Genet. 2010;16(3):133–137. doi:10.4103/0971-6866.73403
  • Kim JH, Hong YC. Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. J Korean Med Sci. 2015;30(3):221–226. doi:10.3346/jkms.2015.30.3.221
  • Stoehr CG, Nolte E, Wach S, et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians. Int J Mol Sci. 2012;13(9):10959–10969. doi:10.3390/ijms130910959
  • Zarei N, Saadat I, Farvardin-Jahromi M. The relationship between NQO1 C609T and CAT C-262Tgenetic polymorphisms and the risk of age-related cataracts. Mol Biol Res Commun. 2015;4(3):143–149.
  • Patti G, Cavallari I, Andreotti F, et al. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs. Nat Rev Cardiol. 2019;16(2):113–130. doi:10.1038/s41569-018-0080-2
  • Martin NJ, Collier AC, Bowen LD, et al. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutat Res. 2009;674(1–2):93–100. doi:10.1016/j.mrgentox.2008.09.009
  • Trpkovic A, Resanovic I, Stanimirovic J, et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci. 2015;52(2):70–85. doi:10.3109/10408363.2014.992063
  • Huang HM, Jiang X, Hao ML, et al. Identification of biomarkers in macrophages of atherosclerosis by microarray analysis. Lipids Health Dis. 2019;18(1):107. doi:10.1186/s12944-019-1056-x
  • Tsai NW, Lee LH, Huang CR, et al. Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome. Crit Care. 2014;18(1):R16. doi:10.1186/cc13695
  • Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98(15):1487–1494. doi:10.1161/01.cir.98.15.1487